# Fresenius Medical Care AG: overview FMS · NYSE · CIK 1333141 · [Healthcare](/sectors/healthcare.md) Pages: [Overview](/companies/fms.md) · [Financials](/companies/fms/financials.md) · [Filings](/companies/fms/filings.md) · [Insiders](/companies/fms/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [17.6](/filings/0001104659-24-025293.md) | [19.4](/filings/0001104659-25-016784.md) | [19.5](/filings/0001104659-26-019005.md) | [19.3](/filings/0001104659-26-019005.md) | [19.6](/filings/0001104659-26-019005.md) | | Gross margin | % | [28.8%](/filings/0001104659-23-024168.md) | [27.4%](/filings/0001104659-23-024168.md) | not reported | not reported | not reported | | Operating margin | % | [10.5%](/filings/0001104659-24-025293.md) | [7.8%](/filings/0001104659-25-016784.md) | [7.0%](/filings/0001104659-26-019005.md) | [7.2%](/filings/0001104659-26-019005.md) | [9.3%](/filings/0001104659-26-019005.md) | | Net margin | % | [5.5%](/filings/0001104659-24-025293.md) | [3.5%](/filings/0001104659-25-016784.md) | [2.6%](/filings/0001104659-26-019005.md) | [2.8%](/filings/0001104659-26-019005.md) | [5.0%](/filings/0001104659-26-019005.md) | | Diluted EPS | $ per share | [3.31](/filings/0001104659-24-025293.md) | [2.30](/filings/0001104659-25-016784.md) | [1.70](/filings/0001104659-26-019005.md) | [1.83](/filings/0001104659-26-019005.md) | [3.36](/filings/0001104659-26-019005.md) | | Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fms/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [PZENA INVESTMENT MANAGEMENT LLC](/funds/1027796.md) | 2026-06-30 | $339.0m | 14,992,081 | | Reduced −60,741 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $98.3m | 4,347,748 | | Added +1,862,938 | | [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $86.5m | 3,826,910 | | Unchanged | | [FIDUCIARY MANAGEMENT INC /WI/](/funds/764532.md) | 2026-06-30 | $66.4m | 2,937,829 | | Reduced −1,524,277 | | [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $43.3m | 1,916,090 | | Added +305,241 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $35.5m | 1,571,805 | | Reduced −69,496 | | [TODD ASSET MANAGEMENT LLC](/funds/1071483.md) | 2026-06-30 | $29.5m | 1,305,386 | | Added +8,843 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $20.3m | 898,668 | | Added +80,666 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $19.5m | 860,302 | | Added +232,633 | | [Quantinno Capital Management LP](/funds/1759654.md) | 2026-06-30 | $11.9m | 527,966 | | Added +186,623 | ## Recent filings [All 500 filings](/companies/fms/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-07 | 18:19 ET | [6-K](/filings/0001104659-26-114302.md) | Report of a foreign private issuer, period 2026-10-07 | 0001104659-26-114302 | | 2026-09-25 | 11:54 ET | [6-K](/filings/0001104659-26-110608.md) | Report of a foreign private issuer, period 2026-09-25 | 0001104659-26-110608 | | 2026-08-27 | 12:14 ET | [6-K](/filings/0001104659-26-102053.md) | Report of a foreign private issuer, period 2026-08-27 | 0001104659-26-102053 | | 2026-08-04 | 11:59 ET | [6-K](/filings/0001104659-26-090080.md) | Report of a foreign private issuer, period 2026-06-30 | 0001104659-26-090080 | | 2026-08-03 | 18:29 ET | [6-K](/filings/0001104659-26-089727.md) | Report of a foreign private issuer, period 2026-08-03 | 0001104659-26-089727 | | 2026-08-03 | 18:28 ET | [6-K](/filings/0001104659-26-089726.md) | Report of a foreign private issuer, period 2026-08-03 | 0001104659-26-089726 | | 2026-08-03 | 18:26 ET | [6-K](/filings/0001104659-26-089725.md) | Report of a foreign private issuer, period 2026-08-03 | 0001104659-26-089725 | | 2026-07-29 | 10:00 ET | [6-K](/filings/0001104659-26-087725.md) | Report of a foreign private issuer, period 2026-07-29 | 0001104659-26-087725 | | 2026-05-28 | 13:12 ET | [6-K](/filings/0001104659-26-067280.md) | Report of a foreign private issuer, period 2026-05-28 | 0001104659-26-067280 | | 2026-05-26 | 13:59 ET | [6-K](/filings/0001104659-26-066087.md) | Report of a foreign private issuer, period 2026-05-26 | 0001104659-26-066087 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-019005.md), filed Feb 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1333141 - Tickers: FMS, FMCQF - Exchange: NYSE - SIC code: 8090 Services-Misc Health & Allied Services, NEC - State of incorporation: not reported - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.